← The Wire
CAINasdaq
Caris Life Sciences, Inc.
Services-Medical Laboratories · TX · CIK 2019410
Caris Life Sciences develops and commercializes molecular profiling solutions and AI to advance precision medicine, primarily in oncology
$5.08B
Market cap
$18.32
Last close
-1.0%
1D
+5.8%
5D
3.8M
Volume
Price · last 39 sessions-2.0%
May 4L $14.55 · H $19.84Jun 29
19
Total filings
Jun 5, 2026
Last filing
12/31
Fiscal year end
Insider Activity
◆ Cluster Buy · 2 insidersIn the 90 days to Dec 11, 2025: 2 insiders bought $110K · 1 sold $1.7M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 11, 2025 | Power Luke ThomasSee Remarks | Sell | 60,850 | $26.56 | $1.6M |
| Dec 11, 2025 | Power Luke ThomasSee Remarks | Sell | 1,400 | $27.16 | $38K |
| Nov 7, 2025 | Denton John RusselSee Remarks | Buy | 4,184 | $24.09 | $101K |
| Nov 7, 2025 | Spetzler David BaxleyPresident | Buy | 400 | $23.85 | $10K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance